Strategic Report Corporate Governance Financial Statements Shareholder Information FINANCIAL STATEMENTS GROUP INCOME STATEMENT GROUP STATEMENT OF COMPREHENSIVE INCOME FOR THE YEAR ENDED 31 MARCH 2017 FOR THE YEAR ENDED 31 MARCH 2017 2017 2016 2017 2016 Notes 000 000 Notes 000 000 Revenue 3 1,245,058 1,016,314 Profit for the year 67,178 45,395 Adjusted Group operating profit 76,118 65,056 Other comprehensive income Net IAS 41 valuation movement on biological assets 16 4,116 951 Other comprehensive income to be reclassified to profit or loss in subsequent periods: Amortisation of customer relationship intangible assets 12 2,108 1,396 Cash flow hedges Gains arising in the year 21 286 61 Group operating profit 4 78,126 62,709 Reclassification adjustments for gains losses included in the income statement 21 61 210 Finance revenue 6 1 Income tax effect 7 37 52 Finance costs 6 639 640 Net other comprehensive income to be reclassified to profit or loss in subsequent periods 188 219 Profit before tax 77,487 62,070 Items not to be reclassified to profit or loss in subsequent periods: Actuarial losses gains on defined benefit pension scheme 26 6,306 14 Taxation 7 15,145 13,022 Income tax effect 7 1,287 3 Profit for the year from continuing operations 62,342 49,048 Net other comprehensive income not to be reclassified to profit or loss in subsequent periods 5,019 11 Other comprehensive income, net of tax 4,831 230 Discontinued operations: Total comprehensive income, net of tax 62,347 45,625 Profit loss for the year from discontinued operations 8 4,836 3,653 Profit for the year 67,178 45,395 Earnings per share pence On profit for the year from continuing operations: COMPANY STATEMENT OF COMPREHENSIVE INCOME Basic 11 124.2p 98.9p FOR THE YEAR ENDED 31 MARCH 2017 Diluted 11 123.7p 98.5p Company profit for the year of 25,317,000 2016: 15,105,000 was equal to total comprehensive income for the year attributable to owners of the parent in both years.
On adjusted profit for the year from continuing operations: Basic 11 120.9p 102.8p Diluted 11 120.4p 102.4p On profit for the year: Basic 11 133.8p 91.5p Diluted 11 133.3p 91.2p On adjusted profit for the year: Basic 11 121.5p 104.7p Diluted 11 121.0p 104.4p 90 Cranswick plc Annual Report & Accounts 2017 Annual Report & Accounts 2017 Cranswick plc 91 Strategic Report Corporate Governance Financial Statements Shareholder Information FINANCIAL STATEMENTS GROUP BALANCE SHEET COMPANY BALANCE SHEET AT 31 MARCH 2017 AT 31 MARCH 2017 2017 2016 2017 2016 Notes 000 000 Notes 000 000 Non-current assets Non-current assets Intangible assets 12 158,487 139,674 Property, plant and equipment 13 566 569 Property, plant and equipment 13 215,660 178,477 Investments in subsidiary undertakings 14 161,474 163,166 Biological assets 16 953 537 Deferred tax assets 7 1,140 983 Total non-current assets 375,100 318,688 Total non-current assets 163,180 164,718 Current assets Current assets Biological assets 16 18,656 10,530 Trade and other receivables 18 39,450 36,162 Inventories 17 62,163 46,163 Cash and short-term deposits 27 1,985 2,175 Trade and other receivables 18 150,620 116,799 Total current assets 41,435 38,337 Financial assets 19 286 61 Total assets 204,615 203,055 Cash and short-term deposits 27 4,107 17,817 Current liabilities Total current assets 235,832 191,370 Trade and other payables 20 51,218 80,617 Total assets 610,932 510,058 Provisions 22 60 60 Current liabilities Income tax payable 870 592 Trade and other payables 20 144,497 121,764 Total current liabilities 52,148 81,269 Financial liabilities 21 5,391 Non-current liabilities Provisions 22 60 60 Financial liabilities 21 14,995 Income tax payable 7,253 6,507 Provisions 22 663 650 Total current liabilities 157,201 128,331 Total non-current liabilities 15,658 650 Non-current liabilities Total liabilities 67,806 81,919 Other payables 20 1,116 1,340 Net assets 136,809 121,136 Financial liabilities 21 15,987 4,687 Equity Deferred tax liabilities 7 2,887 1,781 Called-up share capital 24 5,047 4,984 Provisions 22 2,831 1,467 Share premium account 74,751 69,014 Defined benefit pension scheme deficit 26 9,521 4,449 General reserve 4,000 4,000 Total non-current liabilities 32,342 13,724 Merger reserve 1,806 1,806 Total liabilities 189,543 142,055 Share-based payments 16,683 13,033 Net assets 421,389 368,003 Retained earnings 34,522 28,299 Equity 136,809 121,136 Called-up share capital 24 5,047 4,984 The Companys profit for the year was 25,317,000 2016: 15,105,000.
Share premium account 74,751 69,014 Share-based payments 16,683 13,033 On behalf of the Board Hedging reserve 238 50 Retained earnings 324,670 280,922 Equity attributable to owners of the parent 421,389 368,003 Martin Davey Mark Bottomley Chairman Finance Director On behalf of the Board 23 May 2017 Martin Davey Mark Bottomley Chairman Finance Director 23 May 2017 92 Cranswick plc Annual Report & Accounts 2017 Annual Report & Accounts 2017 Cranswick plc 93 Strategic Report Corporate Governance Financial Statements Shareholder Information FINANCIAL STATEMENTS GROUP STATEMENT OF CASH FLOWS COMPANY STATEMENT OF CASH FLOWS FOR THE YEAR ENDED 31 MARCH 2017 FOR THE YEAR ENDED 31 MARCH 2017 2017 2016 2017 2016 Notes 000 000 Notes 000 000 Operating activities Operating activities Profit for the year 67,178 45,395 Profit for the year 25,317 15,105 Adjustments to reconcile Group profit for the year to net cash inflows from operating activities: Adjustments to reconcile Company profit for the year to net cash inflows from operating activities: Income tax expense 7 15,219 13,276 Dividends received 24,902 14,593 Net finance costs 604 536 Income tax expense 1,918 906 Gain on sale of property, plant and equipment 117 76 Net finance cost 4,797 4,671 Depreciation of property, plant and equipment 13 27,715 21,224 Depreciation of property, plant and equipment 13 34 23 Amortisation of intangible assets 12 2,108 1,396 Reduction in carrying value of investment 14 3,869 Impairment of goodwill 12 4,635 Share-based payments 1,470 1,072 Profit on sale of business 8 4,539 Increase in trade and other receivables 3,098 6,048 Share-based payments 3,650 2,791 Decrease increase in trade and other payables 29,499 28,937 Difference between pension contributions paid and amounts recognised in the income statement 1,234 1,160 Cash generated from operations 20,094 30,073 Release of government grants 215 128 Tax paid 1,311 513 Net IAS 41 valuation movement on biological assets 4,116 951 Net cash used in from operating activities 21,405 29,560 Decrease increase in biological assets 379 229 Cash flows from investing activities Increase decrease in inventories 14,623 2,962 Dividends received 24,902 14,593 Increase decrease in trade and other receivables 24,914 841 Purchase of property, plant and equipment 31 44 Increase in trade and other payables 20,607 5,382 Net cash from investing activities 24,871 14,549 Cash generated from operations 87,702 97,796 Tax paid 14,812 13,962 Cash flows from financing activities Net cash from operating activities 72,890 83,834 Interest paid 4,783 4,640 Proceeds from issue of share capital 788 606 Cash flows from investing activities Issue costs of long term borrowings 1,096 Interest received 1 Repayment of borrowings 22,000 Acquisition of subsidiaries, net of cash acquired 15 56,042 Proceeds from new borrowings 16,000 Purchase of property, plant and equipment 46,969 34,295 Dividends paid 14,565 14,593 Receipt of government grants 229 Net cash used in financing activities 3,656 40,627 Proceeds from sale of property, plant and equipment 517 538 Proceeds from sale of discontinued operations, net of cash surrendered 8 15,524 Net decrease increase in cash and cash equivalents 27 190 3,482 Net cash used in investing activities 86,970 33,527 Cash and cash equivalents at beginning of year 27 2,175 1,307 Cash and cash equivalents at end of year 27 1,985 2,175 Cash flows from financing activities Interest paid 528 444 Proceeds from issue of share capital 788 606 Issue costs of long term borrowings 1,096 Repayment of borrowings 22,000 Proceeds from borrowings 16,000 Dividends paid 14,565 14,593 Repayment of capital element of finance leases and hire purchase contracts 229 Net cash from used in financing activities 370 36,431 Net decrease increase in cash and cash equivalents 27 13,710 13,876 Cash and cash equivalents at beginning of year 27 17,817 3,941 Cash and cash equivalents at end of year 27 4,107 17,817 94 Cranswick plc Annual Report & Accounts 2017 Annual Report & Accounts 2017 Cranswick plc 95 Strategic Report Corporate Governance Financial Statements Shareholder Information FINANCIAL STATEMENTS GROUP STATEMENT OF CHANGES IN EQUITY COMPANY STATEMENT OF CHANGES IN EQUITY FOR THE YEAR ENDED 31 MARCH 2017 FOR THE YEAR ENDED 31 MARCH 2017 Share Share Share-based Hedging Share Share General Merger Share-based capital premium payments reserve Retained Total capital premium reserve reserve payments Retained Total Note a Note b Note e Note f earnings equity Note a Note b Note c Note d Note e earnings equity 000 000 000 000 000 000 000 000 000 000 000 000 000 At 31 March 2015 4,926 65,689 10,242 169 251,685 332,373 At 31 March 2015 4,926 65,689 4,000 1,806 10,242 30,119 116,782 Profit for the year 45,395 45,395 Profit for the year, being total comprehensive income 15,105 15,105 Other comprehensive income 219 11 230 Share-based payments 2,791 2,791 Total comprehensive income 219 45,406 45,625 Scrip dividend 16 2,761 2,777 Share-based payments 2,791 2,791 Share options exercised proceeds 42 564 606 Scrip dividend 16 2,761 2,777 Dividends 17,370 17,370 Share options exercised proceeds 42 564 606 Deferred tax related to changes in equity 140 140 Dividends 17,370 17,370 Current tax related to changes in equity 305 305 Deferred tax related to changes in equity 343 343 At 31 March 2016 4,984 69,014 4,000 1,806 13,033 28,299 121,136 Current tax related to changes in equity 858 858 Profit for the year, being total comprehensive income 25,317 25,317 At 31 March 2016 4,984 69,014 13,033 50 280,922 368,003 Share-based payments 3,650 3,650 Profit for the year 67,178 67,178 Scrip dividend 23 4,989 5,012 Other comprehensive income 188 5,019 4,831 Share options exercised proceeds 40 748 788 Total comprehensive income 188 62,159 62,347 Dividends 19,577 19,577 Share-based payments 3,650 3,650 Deferred tax related to changes in equity 49 49 Scrip dividend 23 4,989 5,012 Current tax related to changes in equity 434 434 Share options exercised proceeds 40 748 788 At 31 March 2017 5,047 74,751 4,000 1,806 16,683 34,522 136,809 Dividends 19,577 19,577 Notes: Deferred tax related to changes in equity 112 112 a Share capital The balance classified as share capital represents the nominal value of ordinary 10 pence shares issued.
Current tax related to changes in equity 1,054 1,054 b Share premium The balance classified as share premium includes the net proceeds in excess of nominal value on issue of the Companys equity share capital, comprising 10 pence At 31 March 2017 5,047 74,751 16,683 238 324,670 421,389 ordinary shares.
c General reserve This reserve arose in 1993 when the High Court of Justice granted permission to reduce the Companys share premium account by 4,000,000 which was credited to a separate reserve named the general reserve.
d Merger reserve Where shares have been issued as consideration for acquisitions, the value of shares issued in excess of nominal value has been credited to the merger reserve rather than to the share premium account.
e Share-based payments reserve This reserve records the fair value of share-based payments expensed in the income statement, and in the case of the Company in relation to share-based payments to employees of subsidiary companies, capital contributions to cost of investments Note 25. f Hedging reserve This reserve records the portion of the gain or loss on a hedging instrument in a cash flow hedge that is determined to be an effective hedge.
96 Cranswick plc Annual Report & Accounts 2017 Annual Report & Accounts 2017 Cranswick plc 97 Strategic Report Corporate Governance Financial Statements Shareholder Information FINANCIAL STATEMENTS NOTES TO THE ACCOUNTS 1.
AUTHORISATION OF FINANCIAL STATEMENTS AND STATEMENT OF COMPLIANCE WITH IFRSs Significant judgements: The Group and Company financial statements of Cranswick plc the Company for the year ended 31 March 2017 were authorised for issue Share-based payments Note 25 measurement of share-based payments.
by the Board of Directors on 23 May 2017 and the balance sheets were signed on the Boards behalf by Martin Davey and Mark Bottomley.
The selection of valuation models requires the use of managements judgement.
The fair value of shareCranswick plc is a public limited company incorporated and domiciled in England and Wales Company number: 1074383, registered office: based payments is estimated as at the date of grant using the Black-Scholes option pricing model.
The Companys ordinary shares are traded on the London Stock Exchange.
Alternative measures Note 31 alternative performance measures.
Management apply judgement to identify the significant non-cash items to exclude when calculating The Groups financial statements have been prepared in accordance with International Financial Reporting Standards IFRS as adopted by adjusted performance measures.
The Board believe alternative measures are useful as they exclude the European Union.
The Companys financial statements have been prepared in accordance with IFRS as adopted by the European Union volatile, one-off and non-cash items.
and as applied in accordance with the provisions of the Companies Act 2006.
The principal accounting policies adopted by the Group and Commercial accruals Note 20 trade and other payables.
by the Company are set out in Note 2.
Advertising and The level of commercial accruals is viewed by management as an area sensitive to a moderate level marketing contributions of judgement in determining the timing and quantum of liabilities to be recognised.
The Company has taken advantage of the exemption provided under section 408 of the Companies Act 2006 not to publish its individual income statement and related notes.
Other estimates and judgements have been applied by management in producing the Annual Report and Accounts including, but not limited to, depreciation and amortisation rates, and provision for impairment of trade receivables.
However, these are not considered to have a significant risk of material adjustment.
ACCOUNTING POLICIES Basis of preparation New standards and interpretations applied The financial statements of Cranswick plc, both consolidated and Company, have been prepared under IFRS as adopted by the European The following accounting standards and interpretations became effective for the current reporting period: Union and in accordance with the Companies Act 2006.
A summary of the principal accounting policies, which have been consistently applied throughout the year and the preceding year, is below.
International Accounting Standards IAS IFRSs Effective date Annual Improvements to IFRSs 2012-2014 Cycle 1 January 2016 The comparative information has been restated in accordance with IFRS 5 to reflect operations classified as discontinued during the year.
IFRS 10 Consolidated Financial Statements amendment application of consolidation exemption 1 January 2016 IFRS 12 Disclosures of Interests in Other Entities amendment 1 January 2016 Basis of consolidation IAS 1 Presentation of Financial Statements amendment 1 January 2016 The Group financial statements consolidate the financial statements of Cranswick plc and its subsidiaries.
The results of undertakings acquired IAS 19 Employee Benefits amendment 1 January 2016 or sold are consolidated for the periods from the date of acquisition or up to the date of disposal.
Acquisitions are accounted for under the IAS 27 Separate Financial Statements amendment 1 January 2016 acquisition method of accounting.
IAS 38 Intangible Assets amendment 1 January 2016 The consolidated financial statements comprise the financial statements of the Group and its subsidiaries as at 31 March 2017.
Control is The application of these standards has not had a material effect on the net assets, results and disclosures of the Group.
achieved when the Group is exposed, or has rights, to variable returns from its involvement with the investee and has the ability to affect those returns through its power over the investee.
New standards and interpretations not applied The IASB and IFRIC have issued a number of new standards and interpretations with an effective date after the date of these financial statements.
Specifically, the Group controls an investee if and only if the Group has: The Directors are in the process of assessing the impact on the Groups and Companys financial statements in particular IFRS 9 and IFRS 15 and power over the investee i. e. existing rights that give it the current ability to direct the relevant activities of the investee : do not consider that those standards which became effective on 1 January 2017 will have a material effect on the net assets, results and exposure, or right, to variable returns from its involvement with the investee: and disclosures of the Group.
The standards not applied are as follows: the ability to use its power over the investee to affect its returns.
International Accounting Standards IAS IFRSs Effective date The Group re-assesses whether or not it controls an investee if facts and circumstances indicate that there are changes to one or more of the Annual improvements to IFRSs 2014-2016 Cycle 1 January 2017 three elements of control.
Consolidation of a subsidiary begins when the Group obtains control over the subsidiary and ceases when the Group IFRS 2 Classification and Measurement of Share-based Payment Transactions 1 January 2018 loses control of the subsidiary.
Assets, liabilities, income and expenses of a subsidiary acquired or disposed of during the year are included in IFRS 9 Financial Instruments 1 January 2018 the statement of comprehensive income from the date the Group gains control until the date the Group ceases to control the subsidiary.
IFRS 15 Revenue from Contracts with Customers including amendments 1 January 2018 IFRS 16 Leases 1 January 2019 When necessary, adjustments are made to the financial statements of subsidiaries to bring their accounting policies into line with the Groups IAS 7 Statement of Cash Flows amendment 1 January 2017 accounting policies.
All intra-Group assets and liabilities, equity, income, expenses and cash flows relating to transactions between members IAS 12 Income Taxes amendment 1 January 2017 of the Group are eliminated in full on consolidation.
IAS 28 Investment in Associates amendment 1 January 2018 IFRIC 22 Foreign Currency Transactions and Advance Consideration 1 January 2018 Judgements and key sources of estimation uncertainty The effective dates stated above are those given in the original IASB IFRIC standards and interpretations.
As the Group prepares its financial statements in accordance The preparation of the Group financial statements requires management to make judgements, estimates and assumptions that affect the with IFRS as adopted by the European Union, the application of new standards and interpretations will be subject to their having been endorsed for use in the EU via the amounts reported for assets and liabilities as at the balance sheet date and the amounts reported for revenues and expenses during the year.
In the majority of cases this will result in an effective date consistent with that given in the original standard or interpretation but the need for endorsement restricts the Groups discretion to early adopt standards.
The Group has not early adopted any of the above standards.
In the process of applying the Groups accounting policies, management has made the following estimations, which have the most significant effect on the amounts recognised in the financial statements: Revenue Revenue is recognised to the extent it is probable that the economic benefits will flow to the Group and the revenue and any associated costs Significant estimates and assumptions: can be measured reliably.
Revenue on the sale of goods is recognised when the significant risks and rewards of ownership of the goods have Share-based payments Note 25 measurement of share-based payments.
passed to the buyer on despatch and represents the value of sales to customers net of discounts, similar allowances and estimates of returns The fair value of share-based payments is estimated using inputs including expected share price volatility, and excludes value added tax.
the expected life of the options and the number of awards that will ultimately vest.
Sales related discounts and similar allowances comprise commercial accruals : Pensions Note 26 pension scheme actuarial assumptions.
Volume rebates and similar allowances which are sales incentives to customers to encourage them to purchase increased volumes and are The valuation of the defined benefit pension scheme is determined using assumptions including mortality, related to total volumes purchased and sales growth.
Advertising and marketing contributions which are directly related to promotions run by customers.
Acquisitions Note 15 fair value adjustments on acquisition include the valuation of intangible assets with inputs based on discount rate, sales growth and customer churn assumptions.
Biological assets Note 16 valuation includes assumptions in relation to mortality and growth rate.
98 Cranswick plc Annual Report & Accounts 2017 Annual Report & Accounts 2017 Cranswick plc 99
